{"id":"https://openalex.org/W2004109623","doi":"https://doi.org/10.1038/sj.bjc.6604264","title":"A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours","display_name":"A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2004109623","doi":"https://doi.org/10.1038/sj.bjc.6604264","mag":"2004109623","pmid":"https://pubmed.ncbi.nlm.nih.gov/18319713","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2266864"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6604264","doi":"https://doi.org/10.1038/sj.bjc.6604264","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604264","pdf_url":"https://www.nature.com/articles/6604264.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6604264.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068550336","display_name":"Sarah Patricia Blagden","orcid":"https://orcid.org/0000-0001-8783-3491","observed_orcids":["https://orcid.org/0000-0001-8783-3491"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S P Blagden","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013897432","display_name":"L. Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L R Molife","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043913115","display_name":"A Seebaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210158028","display_name":"Cancer Research UK Oxford Centre","ror":"https://ror.org/05kgg0s20","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210147381","https://openalex.org/I4210158028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Seebaran","raw_affiliation_strings":["Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944","https://openalex.org/I4210158028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047003355","display_name":"Miranda Payne","orcid":"https://orcid.org/0000-0002-4908-5717","observed_orcids":["https://orcid.org/0000-0002-4908-5717"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210158028","display_name":"Cancer Research UK Oxford Centre","ror":"https://ror.org/05kgg0s20","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210147381","https://openalex.org/I4210158028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Payne","raw_affiliation_strings":["Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944","https://openalex.org/I4210158028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013567386","display_name":"Alison H. M. Reid","orcid":"https://orcid.org/0000-0001-8567-4941","observed_orcids":["https://orcid.org/0000-0001-8567-4941"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A H M Reid","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062742458","display_name":"Andrew S. Protheroe","orcid":"https://orcid.org/0000-0001-9413-0575","observed_orcids":["https://orcid.org/0000-0001-9413-0575"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210158028","display_name":"Cancer Research UK Oxford Centre","ror":"https://ror.org/05kgg0s20","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210147381","https://openalex.org/I4210158028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A S Protheroe","raw_affiliation_strings":["Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944","https://openalex.org/I4210158028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025296466","display_name":"Lakshmi Vasist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L S Vasist","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111769492","display_name":"Daphne D. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D D Williams","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013291304","display_name":"Chester L. Bowen","orcid":"https://orcid.org/0000-0003-3786-0007","observed_orcids":["https://orcid.org/0000-0003-3786-0007"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Bowen","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079408772","display_name":"Steven J. Kathman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S J Kathman","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063597274","display_name":"Jeffrey P. Hodge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J P Hodge","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110684921","display_name":"Mohammed M. Dar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M M Dar","raw_affiliation_strings":["GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development and Clinical Pharmacokinetics, Clinical Pharmacology and Discovery Medical Oncology, Research Triangle Park, 27709, NC, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"J S de Bono","raw_affiliation_strings":["Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital and Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK,","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210158028","display_name":"Cancer Research UK Oxford Centre","ror":"https://ror.org/05kgg0s20","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I40120149","https://openalex.org/I4210147381","https://openalex.org/I4210158028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M R Middleton","raw_affiliation_strings":["Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Cancer Research UK, Oxford Radcliffe Hospitals NHS Trust, The Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK,","institution_ids":["https://openalex.org/I2801179840","https://openalex.org/I2801316944","https://openalex.org/I4210158028"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5072378199"],"corresponding_institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":3.6435,"has_fulltext":true,"cited_by_count":82,"citation_normalized_percentile":{"value":0.92544427,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"98","issue":"5","first_page":"894","last_page":"899"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.6298999786376953,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.33809998631477356,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ispinesib","display_name":"ispinesib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/kinesin-spindle-protein-inhibitor","display_name":"kinesin spindle protein inhibitor","score":0.9769999980926514},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8029999732971191},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/kidney-cancer","display_name":"kidney cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9903078079223633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7509068250656128},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7129330039024353},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6341000199317932},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5025713443756104},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4987008571624756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48349621891975403},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47203245759010315},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4550848603248596},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.4290333390235901},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42859819531440735},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4236100912094116}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016547","descriptor_name":"Kinesins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjc.6604264","doi":"https://doi.org/10.1038/sj.bjc.6604264","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604264","pdf_url":"https://www.nature.com/articles/6604264.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2266864","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2266864","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:18319713","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18319713","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6604264","doi":"https://doi.org/10.1038/sj.bjc.6604264","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6604264","pdf_url":"https://www.nature.com/articles/6604264.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2004109623.pdf","grobid_xml":"https://content.openalex.org/works/W2004109623.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1490431132","https://openalex.org/W1508229957","https://openalex.org/W1839238860","https://openalex.org/W1841504999","https://openalex.org/W1954015558","https://openalex.org/W1988678729","https://openalex.org/W1998276910","https://openalex.org/W2005807653","https://openalex.org/W2029178312","https://openalex.org/W2037015930","https://openalex.org/W2042969122","https://openalex.org/W2048182747","https://openalex.org/W2080849052","https://openalex.org/W2108376231","https://openalex.org/W2120292596","https://openalex.org/W2127405377","https://openalex.org/W2130652363","https://openalex.org/W2136643719","https://openalex.org/W2139248078","https://openalex.org/W2141056749","https://openalex.org/W2155679349","https://openalex.org/W2160059044","https://openalex.org/W2163978496","https://openalex.org/W2260279612","https://openalex.org/W2308310627","https://openalex.org/W2532474449","https://openalex.org/W2604021223","https://openalex.org/W2898898146"],"related_works":["https://openalex.org/W1999184952","https://openalex.org/W7100551121","https://openalex.org/W1954015558","https://openalex.org/W2967961873","https://openalex.org/W3026005843","https://openalex.org/W2240944932","https://openalex.org/W2324763171","https://openalex.org/W2589856228","https://openalex.org/W2063365274","https://openalex.org/W2326846863"],"abstract_inverted_index":{"The":[0,115,177],"aim":[1],"of":[2,18,53,58,131,143,161],"this":[3],"study":[4],"is":[5],"to":[6],"define":[7],"the":[8,144,186],"maximum":[9],"tolerated":[10],"dose":[11,70,99,107],"(MTD),":[12],"safety,":[13],"pharmacokinetics":[14],"(PKs)":[15],"and":[16,37,103,111,133,181,185,201],"efficacy":[17],"ispinesib":[19,33,54,118,132,180,200],"(SB-715992)":[20],"in":[21,109],"combination":[22,187],"with":[23,26,32,122,136,168],"docetaxel.":[24,202],"Patients":[25],"advanced":[27],"solid":[28],"tumours":[29],"were":[30,66,74,85,95,106],"treated":[31,67,96],"(6-12":[34],"mg":[35,40,120,125],"m(-2))":[36],"docetaxel":[38,123,182],"(50-75":[39],"m(-2)).":[41],"Docetaxel":[42],"was":[43,117,183],"administered":[44],"over":[45],"1":[46,57,78],"h":[47],"followed":[48],"by":[49],"a":[50,59,158,171],"1-h":[51],"infusion":[52],"on":[55],"day":[56],"21-day":[60],"schedule.":[61],"At":[62],"least":[63],"three":[64],"patients":[65,94,147],"at":[68,97],"each":[69],"level.":[71],"Blood":[72],"samples":[73],"collected":[75],"during":[76],"cycle":[77],"for":[79,179],"PK":[80,194],"analysis.":[81],"Clinical":[82],"response":[83,160],"assessments":[84],"performed":[86],"every":[87],"two":[88,112],"cycles":[89],"using":[90],"RECIST":[91],"guidelines.":[92],"Twenty-four":[93],"four":[98],"levels.":[100],"Prolonged":[101],"neutropaenia":[102,105],"febrile":[104],"limiting":[108],"six":[110],"patients,":[113],"respectively.":[114],"MTD":[116,178],"10":[119],"m(-2)":[121],"60":[124],"m(-2).":[126],"Pharmacokinetic":[127],"assessment":[128],"demonstrated":[129,188],"concentrations":[130],"docetaxel,":[134],"consistent":[135],"published":[137],"data":[138,195],"from":[139],"single":[140],"agent":[141],"studies":[142],"drugs.":[145],"Seven":[146],"(six":[148],"hormone":[149],"refractory":[150],"prostate":[151],"cancer":[152],"(HRPC),":[153],"one":[154],"renal":[155],"cancer)":[156],"had":[157,170],"best":[159],"stable":[162],"disease":[163],"(>or=18":[164],"weeks).":[165],"One":[166],"patient":[167],"HRPC":[169],"confirmed":[172],">50%":[173],"prostatic-specific":[174],"antigen":[175],"decrease.":[176],"defined":[184],"an":[189],"acceptable":[190],"toxicity":[191],"profile.":[192],"Preliminary":[193],"suggest":[196],"no":[197],"interaction":[198],"between":[199]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}